3,129 results on '"Busch D"'
Search Results
202. Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T-cells: O310
203. The Impacts of Ocean Acidification on Marine Ecosystems and Reliant Human Communities
204. The challenges of detecting and attributing ocean acidification impacts on marine ecosystems
205. 2,3,9,10-Tetramethyl-1,4,8,11-Tetraazacyclo-Tetradeca-1,3,8,10-Tetraene (2,3,9,10-Me4 [14]-1,3,8,10-Tetraene-1,4,8,11-N4 ) Complexes
206. Tris(diamine)chromium(III) Salts
207. 1,4,8,11-Tetraazacyclotetradecane-5,7-Dione (Dioxocyclam) Copper(II) and Aqueous Copper(III) Complexes
208. Characterization of allorestricted T cell receptors (TCR) with specificity for FMNL1 and HER2/neu for potential clinical application: V332
209. Relief from prudential requirements to support the capital markets union
210. Class actions en class settlements in het Amerikaanse financieel recht
211. Supplement commentaar Besluit openbare biedingen Wft
212. Capital Markets Union after Brexit
213. Efforts to strengthen the clearing and settlement framework of the capital markets union
214. A stronger role for the European supervisory authorities in the EU27
215. OTC Derivatives Clearing, Brexit, and the CMU
216. Modernizing the Prospectus Directive
217. Supplement commentaar Wet op het financieel toezicht, artikel 1 en 5:70-83
218. Preventive Restructuring Frameworks
219. Fintech and Alternative Finance in the CMU. The Regulation of Marketplace Investing
220. A policy framework for European personal pensions?
221. Adoptive transfer of cytomegalovirus-specific CD8+ T cells selected by GMP-conform streptamers results in enduring virus clearance in patients after allogeneic stem cell transplantation: V661
222. Vaccination Against H. pylori with Gamma-Glutamyltranspeptidase: Abstract no.: W2.6
223. Agency and Principal Dealing Under the Markets in Financial Instruments Directive (MiFID) I & II
224. Een rol voor de AFM bij de afwikkeling van massaschade?
225. Product Governance und Produktintervention under MiFID II/MiFIR
226. New high-throughput strategies for detection of allergy prone mutant mouse lines using a systemic screening approach: 140
227. Lymphocyte proliferation assay in response to Borrelia burgdorferi in patients with Lyme arthritis: analysis of lymphocyte subsets
228. A 13-year-old adolescent with Kawasaki disease presenting with massive unilateral cervical lymphadenopathy and polyarthritis
229. The 200m Niederaussem tower – design and static approach
230. Design and realisation of cooling tower monitoring
231. The new generation of cooling towers – 200 meters high and of high durability
232. The measures for protecting concrete cooling tower shells newly defined German regulations
233. Modulation of the antigen dose during allergic sensitisation reveals a key role for CD8 + T cells in reducing allergic airway inflammation: 147
234. Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice
235. The European Commission’s Sustainable Finance Action Plan
236. De invloed van de Europese prospectusregels op het privaatrecht
237. Kroniek Financieel Recht
238. Financieel Recht
239. Systemic Risk in the EU Financial Sector. Ten Years after the Great Crash
240. De afwikkeling van beleggingsondernemingen
241. A mouse model for intellectual disability caused by mutations in the X-linked 2'‑O‑methyltransferase Ftsj1 gene
242. Handboek beleggingsondernemingen
243. Vermogensscheiding
244. Beperking aansprakelijkheid AFM en DNB is strijdig met het Europees recht
245. Governance of Financial Institutions
246. A Cross-Sectoral analysis of Micro-Prudential Regulation
247. Flitshandel, andere vormen van algoritmische handel en directe elektronische markttoegang
248. Capital Markets Union
249. Beleggingsondernemingen, ken uw cliënt!
250. Fit and Proper Assessments within the Single Supervisory Mechanism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.